About HILABS INDIA PRIVATE LIMITED
HILABS INDIA PRIVATE LIMITED is a Private Limited Company and was incorporated on Dec 20, 2021 in India. It is registered at Registrar of Companies, ROC Mumbai. Its registered address is The Playce, No. 101, Marathon Maxima, LBS Road, Mulund West, Mumbai, Mumbai, Mumbai, Maharashtra, India, 400080. Its corporate identification number is (CIN) U72200MH2021FTC373590 and its current status is Active. Its industry classification as per MCA is software Publishing, Consultancy And Supply [Software Publishing Includes Production, Supply And Documentation Of Ready-Made (Non-Customized) Software, Operating Systems Software, Business & Other Applications Software, Computer Games Software For All Platforms. Consultancy Includes Providing The Best Solution In The Form Of Custom Software After Analyzing The User’S Needs And Problems. Custom Software Also Includes Made-To-Order Software Based On Orders From Specific Users. Also, Included Are Writing Of Software Of Any Kind Following Directives Of The Users; Software Maintenance, Web-Page Design]. It had a team size of 154 employees as on Jan 31, 2025.
HILABS INDIA PRIVATE LIMITED's last Annual General Meeting (AGM) was held on Sep 30, 2024 as per records from Ministry of Corporate Affairs (MCA). HILABS INDIA PRIVATE LIMITED's authorised share capital is ₹10L and its paid up capital is ₹10L. The current board of directors of HILABS INDIA PRIVATE LIMITED comprises Amit Garg and Prateek Bansal.
HILABS INDIA PRIVATE LIMITED generated between ₹50 Cr and ₹100 Cr in revenue for the financial year ending on Mar 31, 2025.
Contact Details for HILABS INDIA PRIVATE LIMITED
- *****@hilabs.com
- Registered Address
- The Playce, No. 101, Marathon Maxima, LBS Road, Mulund West, Mumbai, Mumbai, Mumbai, Maharashtra, India, 400080
Brands associated with HILABS INDIA PRIVATE LIMITED
Name | Short Description | Founded Year | Location | Current Stage |
|---|---|---|---|---|
Provider of AI-powered applications for healthcare data management and analysis | 2014 | Series B |
Principal Business Activity of HILABS INDIA PRIVATE LIMITED
Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
M | Professional, scientific and technical activities | 74 | Other professional, scientific and technical activities | alx |
Documents of HILABS INDIA PRIVATE LIMITEDFY 25 Available15 mins
Filing Summary
Here is a summary of filing activity and document availability across financial years:
File Type | FY 24-25 | FY 23-24 | FY 22-23 |
|---|---|---|---|
Financial Statements | |||
Annual Returns |
Latest Financials, Share Allotment and Annual Report
The latest filed financial documents, annual reports, and share allotment filings are shown below:
Recent Filings
Below are the most recent filings submitted by the company:
Document Name | Category | Filing Date |
|---|---|---|
Form MSME | Other eForm Documents | Apr 27, 2026 |
Optional attachment(s)- if any | Annual Returns and Balance Sheet eForms | Jan 28, 2026 |
Optional attachment(s)- if any | Annual Returns and Balance Sheet eForms | Jan 28, 2026 |
List of share holders, debenture holders; | Annual Returns and Balance Sheet eForms | Jan 28, 2026 |
Form MGT-7 | Annual Returns and Balance Sheet eForms | Jan 28, 2026 |
Photograph of the registered office of the Company showing external building and name prominently visible | Annual Returns and Balance Sheet eForms | Jan 28, 2026 |
Form CSR-2 | Annual Returns and Balance Sheet eForms | Dec 26, 2025 |
Form CSR-2 | Annual Returns and Balance Sheet eForms | Dec 26, 2025 |
e-Director’s Report | Annual Returns and Balance Sheet eForms | Dec 26, 2025 |
Form CSR-2 | Annual Returns and Balance Sheet eForms | Dec 26, 2025 |
Financials of HILABS INDIA PRIVATE LIMITEDFY 25 Available15 mins
Financial Statement Summary
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
Income Statement | ||||
Revenue | 7594 | 6307 | 4520 | 6404 |
Total Sales | 3488 | 5840 | 1157 | 4014 |
Total Expenses | 8329 | 1831 | 1485 | 1174 |
Operating Expenses | 6149 | 4116 | 8452 | 6812 |
Employee Expenses | 1858 | 3266 | 3263 | 9487 |
Operating Income (EBIT) | 6672 | 1036 | 8764 | 5662 |
Interest Expenses | 2017 | 1997 | 6114 | 4959 |
Expenses from other activities | 8605 | 6701 | 3399 | 9081 |
EBITDA | 3270 | 8798 | 4353 | 7134 |
Taxes | 9186 | 3283 | 3491 | 2391 |
Net Profit | 7615 | 4346 | 7523 | 3263 |
Balance Sheet | ||||
Assets | 9533 | 4189 | 1700 | 4434 |
Accounts Receivables | 1109 | 1987 | 5849 | 5289 |
Inventory | 3640 | 4509 | 1540 | 4967 |
Liabilities | 2713 | 1920 | 7912 | 2490 |
Total Debt | 1376 | 9812 | 1811 | 8136 |
Accounts Payable | 5298 | 6519 | 2303 | 1220 |
Equities | 8277 | 4094 | 4213 | 9451 |
Ratios
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
Profitability Ratios | ||||
EBITDA Margin | 2190 | 4965 | 1786 | 8342 |
EBIT Margin | 5435 | 2452 | 5981 | 8396 |
Net Profit Margin | 3659 | 3836 | 4311 | 2213 |
Return on Assets (ROA) | 3538 | 8895 | 4713 | 3779 |
Return on Equity (ROE) | 8281 | 9514 | 6083 | 5495 |
Return on Capital Employed | 2304 | 1688 | 8647 | 7080 |
Return on Invested Capital | 6240 | 7376 | 8648 | 4911 |
Efficiency Ratios | ||||
Asset Turnover | 7352 | 1138 | 8974 | 9796 |
Receivables Turnover | 7768 | 7506 | 6953 | 6701 |
Days Sales Outstanding | 5265 | 7048 | 1037 | 7522 |
Inventory Turnover | 9267 | 4393 | 7389 | 2700 |
Days Inventory Outstanding | 8702 | 7773 | 9131 | 2469 |
Payables Turnover | 5347 | 4250 | 2753 | 2490 |
Days Payables Outstanding | 1021 | 6358 | 1609 | 8138 |
Liquidity Ratios | ||||
Current Ratio | 2498 | 8654 | 8522 | 5892 |
Quick Ratio | 5646 | 8382 | 9149 | 1883 |
Debt Ratios | ||||
Debt-to-Equity Ratio | 9883 | 9509 | 1111 | 4083 |
Debt Ratio | 1817 | 8286 | 9406 | 1330 |
Interest Coverage Ratio | 9432 | 5219 | 4382 | 1041 |
Debt Service Coverage Ratio | 8583 | 9292 | 3780 | 1397 |
Net Debt/EBITDA | 2000 | 7915 | 8439 | 7956 |
Growth Ratios | ||||
Revenue Growth Rate (CAGR) | 2586 | 5659 | 9482 | 5985 |
Earnings Growth Rate (CAGR) | 3447 | 5760 | 1551 | 2789 |
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
Compounded Annual Growth Rate of HILABS INDIA PRIVATE LIMITED
Revenue CAGR | Growth |
|---|---|
1 Year | 24% |
3 Year | 591 |
5 Year | 162 |
EBITDA CAGR | Growth |
|---|---|
1 Year | 14% |
3 Year | 400 |
5 Year | 992 |
MSME Payment Delays by HILABS INDIA PRIVATE LIMITED
Credit Ratings of HILABS INDIA PRIVATE LIMITED
GSTIN Details of HILABS INDIA PRIVATE LIMITED
Board of Directors and Signatories of HILABS INDIA PRIVATE LIMITED
Board of Directors of HILABS INDIA PRIVATE LIMITED
Name | Designation | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Dec 20, 2021 | 4 Years 6 Months | |
Director | Current | Dec 20, 2021 | 4 Years 6 Months |
Signatories of HILABS INDIA PRIVATE LIMITED
Name | Designation(s) | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Dec 20, 2021 | 4 Years 6 Months | |
Director | Current | Dec 20, 2021 | 4 Years 6 Months |
Legal Cases involving HILABS INDIA PRIVATE LIMITED
Employee Count of HILABS INDIA PRIVATE LIMITED
Date | Employee Count |
|---|---|
Jan 25 | 154 |
Dec 24 | 684 |
Nov 24 | 732 |
Oct 24 | 923 |
Sep 24 | 979 |
Aug 24 | 828 |
Jul 24 | 365 |
Trademarks of HILABS INDIA PRIVATE LIMITED
Patents of HILABS INDIA PRIVATE LIMITED
Competitors & Alternates of HILABS INDIA PRIVATE LIMITED
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Inspiren 2016, Brooklyn (United States), Series B | AI based patient monitoring system for healthcare professionals | $155M | 69/100 | |
2nd | HiLabs 2014, Olney (United States), Series B | Provider of AI-powered applications for healthcare data management and analysis | $41M | 64/100 | |
3rd | Assurecare 1997, Cincinnati (United States), Early Stage | Digital population health management tool for healthcare professionals | $2.24M | 62/100 | |
4th | NeuroFlow 2017, Philadelphia (United States), Series C | Provider of a platform for population health management | $52.5M | 60/100 | |
5th | ApolloMed 2001, Glendale (United States), Public | Integrated population health management company | - | 58/100 | |
6th | Orion Health 1993, Auckland (New Zealand), Acquired | End to End population health and precision medicine solutions for the healthcare community | $25.5M | 57/100 | |
7th | Equality Health 2015, Phoenix (United States), Series B | Provider of population health risk management for providers and organizations | $45M | 56/100 | |
8th | Cricket Health 2015, San Francisco (United States), Series B | Advanced analytics to identify high-risk patients | $120M | 51/100 | |
9th | Provider of generative AI solutions for the healthcare industry | $13M | 55/100 | ||
10th | ZeOmega 2001, Plano (United States), Series A | Provider of software solutions for population healthcare management (PHM) serving payer and provider organizations. | $21.5M | 54/100 |